Vaccine Sciences Lab Capabilities
PPD™ Laboratory services vaccine sciences lab has broad therapeutic and research expertise
PPD Laboratory services partners closely with customers to drive development with well-defined assays, backed by our extensive experience consisting of 15 FDA-approved vaccines and three COVID vaccines that have received Emergency Use Authorization (EUA) or international approval.
Broad therapeutic and research experience
Bacterial agents
- Clostridium difficile (C. diff)
- Diphtheria, tetanus and pertussis (DTP)
- Escherichia coli (E. coli)
- Group B streptococcus
- Haemophilus influenzae type b (Hib)
- Neisseria meningitides (meningococcal)
- Staphylococcus aureus (Staph. aureus)
- Streptococcus pneumoniae (pneumococcal vaccine)
Viral agents
- Coronavirus (SARS-COV-2)
- Cytomegalovirus (CMV)
- Dengue virus
- Epstein-barr virus
- Human immunodeficiency virus (HIV)
- Human metapneumovirus
- Human papillomavirus (HPV)
- Influenza virus
- Lymphocytic choriomeningitis (LCMV)
- Measles, mumps, rubella (MMR)
- Norovirus
- Respiratory syncytial virus (RSV)
- Varicella-zoster virus (VZV/chickenpox and shingles)
We have a collection of assay platforms to support a wide range of development and testing needs
Diverse experience with multiple assay formats
Immunology assays
- ELISA/EIA/HAI
- MSD electrochemiluminescence
- Luminex multiplexed
- Flow cytometry
- Opsonophagocytic assays (OPA/OPK/MOPA)
- Enzyme-linked immunospot (ELISPOT)
- Serum bactericidal assay (SBA)
Molecular assays
- PCR
- Sequencing
- Nucleic acid purification
Learn more about vaccine efficacy testing
Marie Bonhomme, manager of our vaccine sciences lab in Richmond, Virginia, explains immunogenicity testing and how PPD Laboratory services vaccines sciences lab applies this concept to customers’ vaccines development programs
Related resources
Learn more about PPD Laboratory services vaccine sciences lab capabilities.
